Laura Joszt, MA

Laura Joszt headshot

Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including Population Health, Equity & Outcomes; Evidence-Based Oncology™; and The Center for Biosimilars®. She has been working on AJMC since 2014 and has been with AJMC’s parent company, MJH Life Sciences®, since 2011.

She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.

Articles by Laura Joszt, MA

Panelists at the Office of the National Coordinator for Health Information Technology (IT)’s Annual Meeting discussed their perspectives on health IT innovation and expectations for 2018.

Researchers examined the gut microbiome of patients with metastatic melanoma who were being treated with anti–PD-1 immunotherapy, and they determined that patients with a more diverse population of gut bacteria or an abundance of certain types of bacteria were more likely to have their disease controlled for longer.

From 1999-2000 to 2015-2016, there has been a declining trend in high total cholesterol among adults in the United States, according to a report from the CDC. From 2007-2008 to 2015-2016 there was also a decline in low high-density cholesterol. Both types of cholesterol are risk factors for cardiovascular disease, which remains the leading cause of death in the United States.

While it is known that febrile neutropenia is the most common reason for pediatric patients with cancer visiting the emergency department (ED), little had been known about the most common reasons for adult patients with cancer ending up in the ED.

During the final panel at the fall meeting of the ACO & Emerging Healthcare Delivery Coalition® in Nashville, Tennessee, panelists discussed the progress specialties have made in moving to value-based payment models, as well as the challenges facing the industry as a whole. The panel consisted of 3 individuals who provided perspectives from specific specialties, and 1 with an overall policy perspective.



Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo